Does Dr. OMER ASIF SIDDIQUI have financial conflicts of interest?

Dr. OMER ASIF SIDDIQUI (M.D.) has received a total of $4,988 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $4,988 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. OMER ASIF SIDDIQUI?

According to CMS Open Payments data, Dr. OMER ASIF SIDDIQUI received funding from BAYER HEALTHCARE PHARMACEUTICALS ($925), AURINIA PHARMA U.S ($646), and FRESENIUS USA MARKETING ($634).

Does Dr. OMER ASIF SIDDIQUI receive research grants or speaking fees?

Dr. OMER ASIF SIDDIQUI has received $4,988 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. OMER ASIF SIDDIQUI

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Nephrology

Practice Location: MEMPHIS, TN 38104

NPI Number: 1659577278

LIFETIME INDUSTRY VALUE

$4,988

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ASIF SIDDIQUI is a verified Internal Medicine, Nephrology practitioner based in MEMPHIS, TN.

Between 2021 and 2025, Dr. ASIF SIDDIQUI had an overall industry promotional and research financial footprint of $4,988 as recorded in the federal CMS Open Payments database.

$4,988 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ASIF SIDDIQUI's primary funding source is BAYER HEALTHCARE PHARMACEUTICALS, which accounts for $925 (representing 18.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BAYER HEALTHCARE PHARMACEUTICALS

Rank 1

$925

18.6%

AURINIA PHARMA U.S

Rank 2

$646

12.9%

FRESENIUS USA MARKETING

Rank 3

$634

12.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.